IFP Advisors
TVTX icon

IFP Advisors’s Travere Therapeutics TVTX Stock Holding History

IFP Advisors’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$133K Buy
2,261
+21
+0.9% +$1.28K ﹤0.01% 1782
2026
Q2 		$127K Sell
2,240
-58
-3% -$2.57K ﹤0.01% 1807
2026
Q1 		$68.3K Sell
2,298
-76
-3% -$2.27K ﹤0.01% 2077
2025
Q4 		$90.7K Buy
2,374
+2,354
+11,770% +$76.5K ﹤0.01% 1866
2025
Q3 		$478 Buy
+20
New +$376 ﹤0.01% 4183
2025
Q2 		– Sell
-17
Closed -$282 – 4254
2025
Q1 		$305 Hold
17
– – ﹤0.01% 3560
2024
Q4 		$296 Buy
+17
New +$301 ﹤0.01% 3570
2021
Q2 		– Sell
-40
Closed -$789 – 3239
2021
Q1 		$1K Sell
40
-43
-52% -$1.19K ﹤0.01% 2886
2020
Q4 		$3K Buy
83
+19
+30% +$444 ﹤0.01% 2531
2020
Q3 		$1K Hold
64
– – ﹤0.01% 2726
2020
Q2 		$1K Hold
64
– – ﹤0.01% 2625
2020
Q1 		$1K Hold
64
– – ﹤0.01% 2622
2019
Q4 		$1K Buy
+64
New +$817 ﹤0.01% 2731

Other funds holding TVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

IFP Advisors's TVTX Position: Q3 2026 in Review

IFP Advisors increased its Travere Therapeutics (TVTX) stake by 0.94% in Q3 2026, buying an estimated $1.28K and bringing the position to 2,261 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

IFP Advisors first reported a position in TVTX in Q4 2019 and has held it in 13 quarters since. 158 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • IFP Advisors held 2,261 shares of Travere Therapeutics worth $133K as of Q3 2026.
  • IFP Advisors bought 21 Travere Therapeutics shares in Q3 2026, an estimated $1.28K.
  • Travere Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #1782 holding.
  • IFP Advisors first reported a position in Travere Therapeutics in Q4 2019 and has held it in 13 quarters since.
  • 158 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.